Crestline Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-41,179
| Closed | -$5.11M | – | 261 |
|
|
2018
Q2 | $5.11M | Buy |
41,179
+13,666
| +50% | +$1.7M | 0.54% | 20 |
|
|
2018
Q1 | $3.07M | Sell |
27,513
-8,460
| -24% | -$943K | 0.38% | 34 |
|
|
2017
Q4 | $4.3M | Buy |
+35,973
| New | +$4.3M | 0.44% | 18 |
|
|
2017
Q1 | – | Sell |
-1,945
| Closed | -$238K | – | 139 |
|
|
2016
Q4 | $238K | Buy |
+1,945
| New | +$238K | 0.06% | 77 |
|